What is a GLP-1, and how do GLP-1 medications work?

GLP-1 is a natural regulator of appetite and calorie intake. GLP-1 medications, such as semaglutide and tirzepatide, bind to and activate the GLP-1 receptor, the same target the body's own GLP-1 acts on (Wegovy prescribing information; Zepbound prescribing information).

This guide explains published facts and prices. It is not medical advice: a licensed provider who knows your health history decides what is right for you.

What is GLP-1 medication?

Drug labels call these medicines GLP-1 receptor agonists. The Wegovy label notes that the GLP-1 receptor is present in several areas of the brain involved in appetite regulation (Wegovy prescribing information).

Tirzepatide works on a second receptor as well: the Zepbound label says it binds to and activates both the GIP and GLP-1 receptors (Zepbound prescribing information). What that second receptor may add is covered in what is tirzepatide, and how the two medicines compare in semaglutide or tirzepatide.

Which brands are semaglutide and tirzepatide?

Semaglutide and tirzepatide are the two medications our Georgia price ranges cover. Each one has more than one brand name, and each brand has its own label. In short, here is what each label says it is approved for:

Who exactly each brand is approved for, and how each one is taken, is in what is semaglutide and what is tirzepatide.

Is GLP-1 a peptide?

For semaglutide, the Wegovy label answers in its own words. It calls semaglutide a GLP-1 analogue with 94% sequence homology to human GLP-1, meaning its sequence is 94% similar to the body's own GLP-1, and it says the peptide backbone is produced by yeast fermentation (Wegovy prescribing information).

If any product is offered to you as a peptide, ask exactly what it is, whether it is FDA approved, and who prescribes it.

Is GLP-1 safe?

That is a judgment a licensed provider makes for one person, and the labels set out what goes into it. The Wegovy and Zepbound labels each carry a boxed warning about thyroid C-cell tumors: semaglutide caused them in rodents and tirzepatide in rats, and each label says it is unknown whether the medicine causes these tumors in humans, including medullary thyroid carcinoma (MTC), a type of thyroid cancer (Wegovy prescribing information; Zepbound prescribing information).

Both labels say the medicine must not be used by anyone with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Both also list nausea, diarrhea, vomiting, constipation and abdominal pain among the most common side effects, reported in at least 5% of patients (Wegovy prescribing information; Zepbound prescribing information).

Each label lists more warnings than these. For the full list on each one, see what is semaglutide and what is tirzepatide.

What about compounded GLP-1 medications?

Our Georgia ranges come from the prices med spas post, and a posted monthly price may not be for a brand-name product. Here is what FDA says about versions that are not FDA approved (FDA's concerns with unapproved GLP-1 drugs):

So before you start, ask three things: is this the FDA-approved product or a compounded one, who prescribes it, and which pharmacy fills it? FDA's concerns about compounded semaglutide in particular are in what is semaglutide.

What does a month of GLP-1 injections cost in Georgia?

These are estimates from what Georgia med spas and skin clinics publish, not quotes, and we do not name any company. Med spas price these programs by the month:

A month can cover the medication alone or the medication with visits and supplies, so check what each month includes before you compare prices.

Questions to ask your provider

Ask for the medication's name and the full monthly price in writing, so you can compare programs on the same terms.

Sources

  1. Wegovy (semaglutide) injection and tablets, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
  2. Zepbound (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine
  3. Ozempic (semaglutide) injection, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
  4. Rybelsus and Ozempic (oral semaglutide) tablets, FDA-approved prescribing information (Novo Nordisk, label effective January 2026), DailyMed, National Library of Medicine
  5. Mounjaro (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine
  6. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration

Prices mentioned here come from our Georgia med spa cost ranges, built from the prices and cost guides Georgia med spas publish on their public websites, collected September and October 2026.

Find a Georgia med spa